Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Classifica tra le azioni #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Prezzo delle azioni
$1.51
Ultima sincronizzazione: 2024-08-26
Capitalizzazione di mercato
$1.12M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Agile Therapeutics, Inc. (AGRX)

Categoria

EPS per Agile Therapeutics, Inc. (AGRX)
EPS al June 2024 TTM: $-3.23
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Agile Therapeutics, Inc., l’EPS attuale della società (TTM) è $-3.23. Alla fine del 2022, la società aveva un EPS di $-58.79 una diminuzione rispetto a rispetto a quello del 2021, che era di $-63.12K.
Storico EPS per Agile Therapeutics, Inc. da 2012 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-3.23 -51.86%
2023 $-6.71 -88.59%
2022 $-58.79 -99.91%
2021 $-63.12K 4,786.76%
2020 $-1.29K 73.08%
2019 $-746.20 -35.27%
2018 $-1.15K -36.99%
2017 $-1.83K -10.01%
2016 $-2.03K -26.22%
2015 $-2.76K -2.35%
2014 $-2.82K -11.05%
2013 $-3.17K -38.43%
2012 $-5.15K 0.00%
EPS per aziende simili o concorrenti